We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

IHC Detection Kit Combines Sensitive Chemistry and Flexible Software

By LabMedica International staff writers
Posted on 04 Aug 2011
An automated immunohistochemistry (IHC) detection kit combines both sensitive chemistry and flexible software to deliver highly customizable staining.

The OptiView DAB IHC detection kit leads to quicker turnaround time for slides and allows more flexibility for labs. OptiView detection significantly enhances stain quality, allowing pathologists to view IHC assays more clearly than before.

Ventana Medical Systems, Inc. (Oro Valley, AZ, USA), a member of the Roche group (Basel, Switzerland), launched the OptiView DAB IHC detection kit, which is compatible with the entire line of Ventana Benchmark instruments.

Ventana solutions are used in clinical histology and drug development-research laboratories worldwide. The company's "Smart Systems" – intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals.

"OptiView detection is an important, innovative solution to help pathologists be confident that even with the most difficult-to-view markers, they are making the right diagnoses and driving the right patient treatments," said Greg Yap, head of advanced staining assays for Ventana.

Related Links:
Ventana Medical Systems, Inc.
Roche



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Pipette Calibration System
Artel PCS®

Latest Technology News

New CE-Certified Software Advances Whole-Genome Cancer Testing
04 Aug 2011  |   Technology

National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
04 Aug 2011  |   Technology

AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
04 Aug 2011  |   Technology



PURITAN MEDICAL